SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-290610
Filing Date
2019-11-13
Accepted
2019-11-13 09:02:04
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d821827d10q.htm 10-Q 757178
2 EX-3.4 d821827dex34.htm EX-3.4 12353
3 EX-3.5 d821827dex35.htm EX-3.5 7837
4 EX-10.7 d821827dex107.htm EX-10.7 231486
5 EX-31.1 d821827dex311.htm EX-31.1 10224
6 EX-31.2 d821827dex312.htm EX-31.2 10191
7 EX-32.1 d821827dex321.htm EX-32.1 5684
14 GRAPHIC g821827dsp6.jpg GRAPHIC 5763
15 GRAPHIC g821827g1106122146518.jpg GRAPHIC 41307
  Complete submission text file 0001193125-19-290610.txt   4625905

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nltx-20190930.xml EX-101.INS 897177
9 XBRL TAXONOMY EXTENSION SCHEMA nltx-20190930.xsd EX-101.SCH 42419
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20190930_cal.xml EX-101.CAL 43286
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20190930_def.xml EX-101.DEF 174704
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20190930_lab.xml EX-101.LAB 324125
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20190930_pre.xml EX-101.PRE 280934
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 191211846
SIC: 2834 Pharmaceutical Preparations